NYSE American
RGNT
Regentis Biomaterials Ltd.
- Health Care
- Listed 2025
- 1 day
- −4.8%
- 1 month
- −45.9%
- 1 year
- —
$1.97 · Mkt cap $13.8M
At the 6 Aug 2026 close
NYSE American
Regentis Biomaterials Ltd.
$1.97 · Mkt cap $13.8M
At the 6 Aug 2026 close
Regentis Biomaterials Ltd. trades under the ticker RGNT on NYSE American, in the Health Care sector (Industrial Specialties). It has been listed since 2025. Its market capitalisation is $13.8M. The last closing price was $1.97, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing.
This page exists because RGNT is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.